Does cosentyx use impact live vaccine response?

Can live vaccines be given with Cosentyx?

Cosentyx inhibits interleukin-17A, weakening immune defenses against bacteria and fungi. This raises concern for live vaccines, which rely on a controlled infection to generate immunity. Cosentyx may therefore impair both the safety and effectiveness of live vaccines.

Why do guidelines advise against live vaccines during Cosentyx?

Current prescribing information states that patients should not receive live vaccines while taking Cosentyx. The manufacturer warns against their use because the weakened immune response could turn a supposedly safe live attenuated virus or bacterium into an actual infection.

How long after stopping Cosentyx can a live vaccine be given?

The manufacturer recommends waiting at least five half-lives of secukinumab—the active ingredient in Cosentyx—before receiving a live vaccine. Five half-lives of secukinumab are roughly 22 weeks, or five months, after the letzten dose.

What happens if a live vaccine is received while on Cosentyx?

No clinical trials have directly tested live vaccines with Cosentyx. Data from other IL-17 inhibitors show increased risk of disseminated infection from live vaccines. Risk assessment therefore relies on the class-wide warning issued by the manufacturer.

What non-live vaccine options remain available?

Most inactivated vaccines are considered safe with Cosentyx. Patients can still receive influenza shots (non-live versions), pneumonia vaccines, and COVID-19 vaccines without the same risk.